Tagged barrett-s-esophagus

Symple Surgical Awarded SBIR Phase I Grant for Novel Radiometry‐Guided Ablation Catheter to Reliably Treat Barrett's Esophagus
Press Release

Symple Surgical Awarded SBIR Phase I Grant for Novel Radiometry‐Guided Ablation Catheter to Reliably Treat Barrett's Esophagus

 The National Institutes of Health Small Business Innovation Research Program Supports Symple Surgical's Microwave Ablation Technology Read More
Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus
Press Release

Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus

 By combining Deciphex's unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI. Read More
Aqua Medical Announces Final $8.2 Million Equity Investment Led by ShangBay Capital to Close Its $15.5 Million Series A Financing Round
Press Release

Aqua Medical Announces Final $8.2 Million Equity Investment Led by ShangBay Capital to Close Its $15.5 Million Series A Financing Round

 Investment will be used to advance its novel vapor-based ablation system to treat precancerous conditions and metabolic disease such as type 2 diabetes in the gastrointestinal (GI) tract. Read More
Cernostics Announces Blinded, Independent Validation of TissueCypher(R) Performance for Predicting Risk of Progression to Esophageal Cancer in Patients With Non-Dysplastic BE
Press Release

Cernostics Announces Blinded, Independent Validation of TissueCypher(R) Performance for Predicting Risk of Progression to Esophageal Cancer in Patients With Non-Dysplastic BE

 Study further validates TissueCypher(R) as the first and only precision medicine test proven to provide actionable data for predicting patient progression to high-grade dysplasia and esophageal adenocarcinoma Read More
Cernostics Announces Groundbreaking Data Demonstrating TissueCypher Performance for Predicting Risk of Progression to EAC in Patients With Non-Dysplastic BE
Press Release

Cernostics Announces Groundbreaking Data Demonstrating TissueCypher Performance for Predicting Risk of Progression to EAC in Patients With Non-Dysplastic BE

 First-of-its-kind precision medicine test for esophageal pinch biopsies identifies high-risk, non-dysplastic BE patients that progress to EAC at rates higher than expert-confirmed LGD Read More
TissueCypher® Further Validated to Accurately Risk Stratify Barrett's Esophagus Patients With Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences
Press Release

TissueCypher® Further Validated to Accurately Risk Stratify Barrett's Esophagus Patients With Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences

 Data presented at ACG, UEGW illustrates the fourth independent validation of TissueCypher performance for risk stratifying non-dysplastic Barrett's esophagus (NDBE) patients; expands indication for testing low-grade dysplasia (LGD) Read More